Inventor · disambiguated record
Frédéric André De Ceuninck
Also filed as: DE CEUNINCK FRÉDÉRIC · DE CEUNINCK FRÉDÉRIC ANDRÉ
6 granted patents·1 pending application·10 citations·filing 2015–2023
73Inventor score
Top patents by PatentIndex Score
7 records- 0190US9926281B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2015·Granted Mar 27, 2018·6 cites·18 claims
- 0288US10487060B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2018·Granted Nov 26, 2019·4 cites·28 claims
- 0369US11718588B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2021·Granted Aug 8, 2023·0 cites·16 claims
- 0468US10941117B25-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2019·Granted Mar 9, 2021·0 cites·4 claims
- 0554US2025215091A1Anti-GAL3 Antibodies and CompositionsSERVIER LAB·Filed 2023·Application pending·0 cites
- 0638US10829478B25-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Nov 10, 2020·0 cites·37 claims
- 0737US10550100B25-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Feb 4, 2020·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Frédéric André De Ceuninck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →